Nuvation Bio's market cap is currently $766.28M. The company's EPS TTM is $-2.17; its P/E ratio is ―; Nuvation Bio is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -222.00K	$ -484.00K	$ -368.00K	$ -103.00K	$ 0.00
Operating Income	$ -99.82M	$ -119.73M	$ -93.32M	$ -43.55M	$ -32.10M
EBITDA	$ -99.60M	$ -119.53M	$ -89.35M	$ -43.45M	$ -32.09M
Net Income	$ -75.80M	$ -88.66M	$ -79.73M	$ -39.50M	$ -33.55M
Balance Sheet
Cash & Short-Term Investments	$ 611.21M	$ 661.01M	$ 765.39M	$ 215.75M	$ 118.87M
Total Assets	$ 621.48M	$ 672.14M	$ 776.15M	$ 221.79M	$ 120.95M
Total Debt	$ 4.01M	$ 4.26M	$ 3.06M	$ 0.00	$ 0.00
Net Debt	$ -38.64M	$ -96.84M	$ -129.37M	$ -29.75M	$ -3.47M
Total Liabilities	$ 16.36M	$ 17.07M	$ 30.15M	$ 6.71M	$ 3.20M
Stockholders' Equity	$ 605.12M	$ 655.08M	$ 746.00M	$ 215.08M	$ 117.75M
Cash Flow
Free Cash Flow	$ -68.07M	$ -96.48M	$ -68.47M	$ -36.67M	$ -25.09M
Operating Cash Flow	$ -68.00M	$ -96.11M	$ -68.19M	$ -36.53M	$ -24.43M
Investing Cash Flow	$ 8.92M	$ 63.46M	$ -454.67M	$ -70.32M	$ -115.86M
Financing Cash Flow	$ 628.00K	$ 1.33M	$ 625.53M	$ 133.13M	$ 143.62M

Currency in USD

Nuvation Bio Earnings and Revenue History

Income Statement >

Nuvation Bio Debt to Assets

Balance Sheet >

Nuvation Bio Cash Flow

Cash Flow >

Nuvation Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing